Comparison of safety and short-term outcomes of septostomy and direct tunnel passage techniques in percutaneous patent foramen ovale closure: a multicenter experience

MakaleAçık ErişimScopus SJRQ1
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Background – Percutaneous closure of a patent foramen ovale (PFO) is an established therapeutic strategy for patients with cryptogenic stroke (CS). This study aimed to compare the procedural safety, efficacy, and short-term clinical outcomes of atrial septostomy vs. standard direct tunnel passage techniques for PFO closure. Methods – We retrospectively analyzed consecutive patients who underwent PFO closure for CS at four centers between January 2010 and December 2020. Demographic characteristics, vascular risk factors, Risk of Paradoxical Embolism (RoPE) scores, PFO anatomical features, procedural details, and clinical outcomes were compared between patients treated with atrial septostomy and those undergoing direct tunnel passage. Continuous variables are presented as mean ± standard deviation or median [interquartile range], and categorical variables as counts and percentages. Results – A total of 246 patients were included (mean age 40.5 ± 9.8 years), of whom 69.9% presented with ischemic stroke and 30.1% with transient ischemic attack (TIA). Atrial septostomy was performed in 106 patients (43.1%), while 140 patients (56.9%) underwent direct tunnel passage. Baseline clinical characteristics were comparable between groups; however, the septostomy group exhibited significantly more complex PFO anatomy, including atrial septal aneurysm (69.8% vs. 39.3%), septal hypermobility (62.3% vs. 34.3%), and spontaneous shunting at rest (85.8% vs. 50.7%; all p < 0.001). Procedure duration was similar between groups (41.1 ± 10.2 vs. 40.7 ± 13.8 min; p = 0.83), and technical success was achieved in nearly all cases. No major procedural complications occurred. Minor adverse events were infrequent and comparable (8.4% vs. 4.3%; p = 0.20). At six-month follow-up, residual shunt rates were numerically lower in the septostomy group (6.6% vs. 11.4%; p = 0.27). No TIAs were observed in the septostomy group, whereas a 3.6% incidence was noted in the direct passage group (p = 0.08). New-onset atrial arrhythmia occurred in two patients (1.9%) in the septostomy group and in none of the direct passage group (p = 0.18). Conclusion – Despite being applied in patients with more complex PFO anatomy, atrial septostomy demonstrated comparable procedural safety, technical success, and short-term efficacy to standard direct tunnel passage. Tunnel length emerged as an independent predictor of residual shunt, regardless of closure technique. In experienced centers, atrial septostomy appears to be a safe and practical alternative for anatomically challenging PFO closures.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10331Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3389/fcvm.2026.1741158Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
0
OpenAlex
0
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCoskun, Senol
dc.contributor.authorTiryakioğlu, Selma Kenar
dc.contributor.authorMirzamidinov, Didar
dc.contributor.authorInan, Duygu
dc.contributor.authorKilicgedik, Alev
dc.contributor.authorSahin, Tayfun
dc.contributor.authorKilic, Teoman
dc.date.accessioned2026-10-27T23:47:25.034548774Z
dc.date.available2026-10-27T23:47:25.034548774Z
dc.date.issued2026
dc.description.abstractBackground – Percutaneous closure of a patent foramen ovale (PFO) is an established therapeutic strategy for patients with cryptogenic stroke (CS). This study aimed to compare the procedural safety, efficacy, and short-term clinical outcomes of atrial septostomy vs. standard direct tunnel passage techniques for PFO closure. Methods – We retrospectively analyzed consecutive patients who underwent PFO closure for CS at four centers between January 2010 and December 2020. Demographic characteristics, vascular risk factors, Risk of Paradoxical Embolism (RoPE) scores, PFO anatomical features, procedural details, and clinical outcomes were compared between patients treated with atrial septostomy and those undergoing direct tunnel passage. Continuous variables are presented as mean ± standard deviation or median [interquartile range], and categorical variables as counts and percentages. Results – A total of 246 patients were included (mean age 40.5 ± 9.8 years), of whom 69.9% presented with ischemic stroke and 30.1% with transient ischemic attack (TIA). Atrial septostomy was performed in 106 patients (43.1%), while 140 patients (56.9%) underwent direct tunnel passage. Baseline clinical characteristics were comparable between groups; however, the septostomy group exhibited significantly more complex PFO anatomy, including atrial septal aneurysm (69.8% vs. 39.3%), septal hypermobility (62.3% vs. 34.3%), and spontaneous shunting at rest (85.8% vs. 50.7%; all p < 0.001). Procedure duration was similar between groups (41.1 ± 10.2 vs. 40.7 ± 13.8 min; p = 0.83), and technical success was achieved in nearly all cases. No major procedural complications occurred. Minor adverse events were infrequent and comparable (8.4% vs. 4.3%; p = 0.20). At six-month follow-up, residual shunt rates were numerically lower in the septostomy group (6.6% vs. 11.4%; p = 0.27). No TIAs were observed in the septostomy group, whereas a 3.6% incidence was noted in the direct passage group (p = 0.08). New-onset atrial arrhythmia occurred in two patients (1.9%) in the septostomy group and in none of the direct passage group (p = 0.18). Conclusion – Despite being applied in patients with more complex PFO anatomy, atrial septostomy demonstrated comparable procedural safety, technical success, and short-term efficacy to standard direct tunnel passage. Tunnel length emerged as an independent predictor of residual shunt, regardless of closure technique. In experienced centers, atrial septostomy appears to be a safe and practical alternative for anatomically challenging PFO closures.
dc.identifier.articlenumber1741158
dc.identifier.doi10.3389/fcvm.2026.1741158
dc.identifier.issn2297-055X
dc.identifier.scopus2-s2.0-105041014277
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10331
dc.identifier.volume13
dc.language.isoen
dc.publisherFrontiers Media SA
dc.relation.ispartofFrontiers in Cardiovascular Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectatrial septostomy
dc.subjectcomplications
dc.subjectcryptogenic stroke
dc.subjectpatent foramen ovale
dc.subjectPFO closure
dc.subjectprocedural safety
dc.subject.otheradult
dc.subject.otherArticle
dc.subject.otheratrial fibrillation
dc.subject.otheratrial septostomy
dc.subject.otherbody mass
dc.subject.othercerebrovascular accident
dc.subject.otherclinical outcome
dc.subject.othercohort analysis
dc.subject.othercomparative study
dc.subject.othercontrolled study
dc.subject.othercoronary artery disease
dc.subject.otherdemographics
dc.subject.otherdiabetes mellitus
dc.subject.otherdirect tunnel passage technique
dc.subject.otherdisease assessment
dc.subject.otherechocardiography
dc.subject.otherfemale
dc.subject.otherfollow up
dc.subject.othergroin hematoma
dc.subject.otherheart atrium septum defect
dc.subject.otherhuman
dc.subject.otherhyperlipidemia
dc.subject.otherhypertension
dc.subject.otherischemic stroke
dc.subject.othermale
dc.subject.othermulticenter study
dc.subject.otherobservational study
dc.subject.otherparadoxical embolism
dc.subject.otherpatent foramen ovale
dc.subject.otherretrospective study
dc.subject.otherrisk factor
dc.subject.otherrisk of paradoxical embolism score
dc.subject.othersmoking
dc.subject.othersurgical technique
dc.subject.othertransient ischemic attack
dc.subject.othertransthoracic echocardiography
dc.titleComparison of safety and short-term outcomes of septostomy and direct tunnel passage techniques in percutaneous patent foramen ovale closure: a multicenter experience
dc.typeArticle
rdl.citation.openalex0
rdl.citation.scopus0
rdl.oa.statusgold
rdl.oa.urlhttps://public-pages-files-2025.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1741158/pdf
rdl.scopus.quartileQ1
rdl.sdgSDG03
rdl.source.indexSCOPUS